Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy — Stella

Home/Diabetic Retinopathy/

View on ClinicalTrials.gov

Recruiting

Back to Diabetic Retinopathy trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

China

Xuanwu Hospital, Capital Medical University, Beijing, Beijing Municipality

Xuanwu Hospital, Beijing, Beijing Municipality

Key details

Sponsor

Xuxiang Zhang, MD

Collaborators

Xuanwu Hospital, Beijing

Enrollment target

~68 participants

Started

April 2025

Primary completion

April 2026

Age range

40 Years – 80 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.